Bio Tech

Biotech Top Gainers: Genetic Technologies Limited (NASDAQ:GENE), Esperion Therapeutics (NASDAQ:ESPR), Can-Fite BioPharma (NYSEMKT:CANF), Egalet Corporation (NASDAQ:EGLT), Evogene (NYSE:EVGN)

February 5, 2015 at 11:57 am 0 comments

On 29 January Genetic Technologies Limited (NASDAQ: GENE) reported that up to 6 new breast diagnosis/treatment centres are expected to begin offering BREVAGenplus® to their at-risk patients in a systematic broad fashion in the January to March timeframe, with aRead More

Biotech Unusual Volume: Genetic Technologies Limited (NASDAQ:GENE), Hemispherx Biopharma (NYSEMKT:HEB), Esperion Therapeutics (NASDAQ:ESPR), Onconova Therapeutics (NASDAQ:ONTX), Ardelyx (NASDAQ:ARDX)

February 4, 2015 at 1:29 pm 0 comments

Genetic Technologies Limited (NASDAQ:GENE) on 29 January reported that it has entered into a A$24 million Standby Equity Placement Facility Agreement with the Kentgrove Capital Growth Fund to strengthen the Company’s funding position. On Tuesday shares of Genetic Technologies LimitedRead More

Biotech Losers: Xenoport (NASDAQ:XNPT), Onconova Therapeutics (NASDAQ:ONTX), Advaxis (NASDAQ:ADXS), Regado Biosciences (NASDAQ:RGDO), Omeros Corporation (NASDAQ:OMER)

February 4, 2015 at 1:28 pm 0 comments

XenoPort, Inc. (NASDAQ: XNPT) on 29 January announced the pricing of $100 million aggregate principal amount of 2.50% Convertible Senior Notes due 2022 in a private placement to qualified institutional buyers pursuant to Rule 144A (the “offering”) under the SecuritiesRead More

Biotech Gainers: Genetic Technologies Limited (NASDAQ:GENE), Esperion Therapeutics (NASDAQ:ESPR), Theravance Inc. (NASDAQ:THRX), RXi Pharmaceuticals Corporation (NASDAQ:RXII), Recro Pharma (NASDAQ:REPH)

February 4, 2015 at 1:27 pm 0 comments

Genetic Technologies Limited (NASDAQ:GENE) on 29 January announced that up to 6 new breast diagnosis/treatment centers are expected to begin offering BREVAGenplus? to their at-risk patients in a systematic broad fashion in the January to March timeframe, with a growingRead More

Biotech Bears: Amicus Therapeutics (NASDAQ:FOLD), Genetic Technologies Limited (NASDAQ:GENE), Ardelyx (NASDAQ:ARDX), Enanta Pharmaceuticals (NASDAQ:ENTA), Spark Therapeutics (NASDAQ:ONCE)

February 3, 2015 at 1:01 pm 0 comments

Amicus Therapeutics (NASDAQ:FOLD), announced that 2 oral presentations and 6 posters highlighting its development programs for lysosomal storage diseases will be included at the 11th Annual Lysosomal Disease Network WORLD Symposium (LDN WORLD), to be held February 9-13, 2015 inRead More

Biotech Bulls: Curis (NASDAQ:CRIS), CorMedix (NYSEMKT:CRMD), Theravance Biopharma (NASDAQ:TBPH), GenVec (NASDAQ:GNVC), Genocea Biosciences (NASDAQ:GNCA)

February 3, 2015 at 1:00 pm 0 comments

On 21st January Curis, Inc. (NASDAQ:CRIS), and Aurigene Discovery Technologies Limited, announced that they have entered into an exclusive collaboration agreement focused on immuno-oncology and selected precision oncology targets. On Monday shares of Curis, Inc. (NASDAQ:CRIS) closed at $1.95. Company’sRead More

Biotech Volatile Stocks: ImmunoGen (NASDAQ:IMGN), Genetic Technologies Limited (NASDAQ:GENE), TrovaGene (NASDAQ:TROV), Repligen Corporation (NASDAQ:RGEN), Vitae Pharmaceuticals (NASDAQ:VTAE)

February 2, 2015 at 1:02 pm 0 comments

ImmunoGen, Inc. (NASDAQ:IMGN) reported fiscal second quarter earnings. The company announced net income of $13.6 million, or $0.16 per share, substantially -$0.21- above Capital IQ’s Consensus Estimate of a $0.05 per share loss, and also up from the same quarterRead More

Biotech Bearish Stocks: Genetic Technologies Limited (NASDAQ:GENE), EPIRUS Biopharmaceuticals (NASDAQ:EPRS), TRACON Pharmaceuticals (NASDAQ:TCON), bluebird bio (NASDAQ:BLUE), Xenoport (NASDAQ:XNPT)

February 2, 2015 at 1:01 pm 0 comments

Genetic Technologies Limited (NASDAQ:GENE) on 29 January announced that up to 6 new breast diagnosis/treatment centers are expected to begin offering BREVAGenplus? to their at-risk patients in a systematic broad fashion in the January to March timeframe, with a growingRead More

Biotech Bullish Stocks: ImmunoGen (NASDAQ:IMGN), Spark Therapeutics (NASDAQ:ONCE), Biogen Idec Inc. (NASDAQ:BIIB), Regado Biosciences (NASDAQ:RGDO), CorMedix (NYSEMKT:CRMD)

February 2, 2015 at 1:00 pm 0 comments

For the Company’s quarter ended December 31, 2014 (2Q, FY2015), ImmunoGen Inc. (NASDAQ:IMGN) reported net income of $13.6 million, or $0.16 per basic and diluted share, compared to net income of $3.8 million, or $0.04 per basic and diluted share,Read More

Biotech Top Gainers: Genetic Technologies Limited (NASDAQ:GENE), CorMedix (NYSEMKT:CRMD), Atara Biotherapeutics (NASDAQ:ATRA), Omeros Corporation (NASDAQ:OMER), Cleveland BioLabs (NASDAQ:CBLI)

January 30, 2015 at 1:32 pm 0 comments

Genetic Technologies Limited (NASDAQ: GENE) is pleased to report that up to 6 new breast diagnosis/treatment centres are expected to begin offering BREVAGenplus® to their at-risk patients in a systematic broad fashion in the January to March timeframe, with aRead More